On July 10, 2024, FOXO Technologies Inc., a biotechnology company focused on improving human health and longevity, received a notice from NYSE Regulation stating that the company is not in compliance with the NYSE American continued listing standards. The noncompliance is due to a reported stockholders' deficit of $14.9 million as of March 31, 2024, and net losses in the three most recent fiscal years. Interim CEO Mark White expressed regret over the delinquency, attributing it to short-term capital allocation strategies, and conveyed the company's intention to present a compliance plan, highlighting planned acquisitions expected to generate significant cash flow. FOXO Technologies must adhere to the procedures outlined in Section 1009 of the NYSE Company Guide and address previous equity and fee noncompliance issues. The company has until July 16, 2024, to confirm receipt of the notice and discuss developments with NYSE. While FOXO Technologies aims to regain compliance, there is no guarantee of meeting the NYSE American listing standards. The company issued a press release on July 16, 2024, regarding the notice and its commitment to compliance.

On July 10, 2024, FOXO Technologies Inc., a biotechnology company focused on improving human health and longevity, received a notice from NYSE Regulation stating that the company is not in compliance with the NYSE American continued listing standards. The noncompliance is due to a reported stockholders' deficit of $14.9 million as of March 31, 2024, and net losses in the three most recent fiscal years. Interim CEO Mark White expressed regret over the delinquency, attributing it to short-term capital allocation strategies, and conveyed the company's intention to present a compliance plan, highlighting planned acquisitions expected to generate significant cash flow. FOXO Technologies must adhere to the procedures outlined in Section 1009 of the NYSE Company Guide and address previous equity and fee noncompliance issues. The company has until July 16, 2024, to confirm receipt of the notice and discuss developments with NYSE. While FOXO Technologies aims to regain compliance, there is no guarantee of meeting the NYSE American listing standards. The company issued a press release on July 16, 2024, regarding the notice and its commitment to compliance.